Treatment with naringin (60 mg/kg/d) normalized the expression of NF-κB in T2D myocardium compared to untreated tissue (p < 0.001) (Figure 4C), without affecting the expression in control naringin treated myocardium (p = 0.94). Here, NFKB1 is linked to type 2 diabetes mellitus.